STW goes off message; Enero on track
STW's 8% yield looks enticing, especially compared to Enero which hasn’t paid a dividend in four years. But there’s much more to the story.
Caltex: A fuel's errand
Long derided as one of the worst businesses in the land, Caltex is changing for the better.
HPI has the edge over Industria
With HPI continuing to purchase hotels, Nathan Bell compares it to Industria, an industrial property trust with a seemingly attractive yield.
Caltex: when to sell?
The transformation of this company is coming to an end. It’s time to think about an exit strategy for the new look Caltex.
ResMed set to awaken
This Aussie healthcare icon has been marking time for over a year, but there are good reasons why that may be about to change.
The 'good growth & okay yield' mini portfolio
Income investors have been left to pick over the bones of the safety bubble and are paying too much for yield. But there's another way to get good returns.
ResMed set to awaken
This manufacturer of treatments for sleep apnea has faced a number of problems over the past year, but its future looks brighter.
Brickworks and Soul Patts: Results 2014
Headline profits don't tell the complete story of this incestuous pair but digging deeper makes one thing clear: both businesses are cheap.
Recall downgraded to Sell
The takeover rumours may be buzzing and its share price up, but Recall's fundamentals haven't budged.
Goodman Group: Back from the brink
Goodman Group is in the right place at the right time, but its markets look 'frothy' according to CEO Greg Goodman, and there's no margin of safety in its shares.
Don't get hooked on Tassal
A great product doesn't always make a great company - and the weather isn't making aquaculture any easier.
Get your claws into Santos
When the market gets petty, investors should get greedy. Gaurav Sodhi explains why Santos is worth an upgrade.
Call 1300 880 160
Start a chat
Schedule a call
